Michael
0000-0003-4078-2599
Organisation
3 papers found
Refreshing results…
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer
Missing publications? Search for publications with a matching author name.